These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 36707268)

  • 21. Ketamine treatment for depression: opportunities for clinical innovation and ethical foresight.
    Singh I; Morgan C; Curran V; Nutt D; Schlag A; McShane R
    Lancet Psychiatry; 2017 May; 4(5):419-426. PubMed ID: 28395988
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Features of dissociation differentially predict antidepressant response to ketamine in treatment-resistant depression.
    Niciu MJ; Shovestul BJ; Jaso BA; Farmer C; Luckenbaugh DA; Brutsche NE; Park LT; Ballard ED; Zarate CA
    J Affect Disord; 2018 May; 232():310-315. PubMed ID: 29501990
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Can ketamine be a safe option for treatment-resistant bipolar depression?
    Singh B; Vande Voort JL; Frye MA; Kung S
    Expert Opin Drug Saf; 2022 Jun; 21(6):717-720. PubMed ID: 35188015
    [No Abstract]   [Full Text] [Related]  

  • 24. Ketamine: Future Treatment For Unresponsive Depression?
    Frere M; Tepper J
    Ir Med J; 2016 Sep; 109(8):453. PubMed ID: 28124853
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Suicidality in treatment resistant depression: perspective for ketamine use.
    Jakuszkowiak-Wojten K; Gałuszko-Węgielnik M; Wilkowska A; Słupski J; Włodarczyk A; Górska N; Szarmach J; Szałach ŁP; Wiglusz MS; Krysta K; Cubała WJ
    Psychiatr Danub; 2019 Sep; 31(Suppl 3):258-260. PubMed ID: 31488737
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A systematic review of therapeutic ketamine use in children and adolescents with treatment-resistant mood disorders.
    Kim S; Rush BS; Rice TR
    Eur Child Adolesc Psychiatry; 2021 Oct; 30(10):1485-1501. PubMed ID: 32385697
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Maintenance of antidepressant and antisuicidal effects by D-cycloserine among patients with treatment-resistant depression who responded to low-dose ketamine infusion: a double-blind randomized placebo-control study.
    Chen MH; Cheng CM; Gueorguieva R; Lin WC; Li CT; Hong CJ; Tu PC; Bai YM; Tsai SJ; Krystal JH; Su TP
    Neuropsychopharmacology; 2019 Nov; 44(12):2112-2118. PubMed ID: 31421635
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effectiveness of repeated intravenous ketamine on depressive symptoms, suicidal ideation and functional disability in adults with major depressive disorder and bipolar disorder: Results from the Canadian Rapid Treatment Center of Excellence.
    McIntyre RS; Rodrigues NB; Lee Y; Lipsitz O; Subramaniapillai M; Gill H; Nasri F; Majeed A; Lui LMW; Senyk O; Phan L; Carvalho IP; Siegel A; Mansur RB; Brietzke E; Kratiuk K; Arekapudi AK; Abrishami A; Chau EH; Szpejda W; Rosenblat JD
    J Affect Disord; 2020 Sep; 274():903-910. PubMed ID: 32664031
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Esketamine for treatment resistant depression: a trick of smoke and mirrors?
    Gastaldon C; Papola D; Ostuzzi G; Barbui C
    Epidemiol Psychiatr Sci; 2019 Dec; 29():e79. PubMed ID: 31841104
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rethinking ketamine and esketamine action: Are they antidepressants with mood-stabilizing properties?
    d'Andrea G; Pettorruso M; Lorenzo GD; Mancusi G; McIntyre RS; Martinotti G
    Eur Neuropsychopharmacol; 2023 May; 70():49-55. PubMed ID: 36867895
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Maintaining the initial clinical response after ketamine in bipolar and unipolar depression: an important next-step challenge.
    Iosifescu DV
    J Clin Psychiatry; 2015 Jun; 76(6):738-40. PubMed ID: 26132676
    [No Abstract]   [Full Text] [Related]  

  • 32. Ketamine for Depression in Older Adults.
    Subramanian S; Lenze EJ
    Am J Geriatr Psychiatry; 2021 Sep; 29(9):914-916. PubMed ID: 33509675
    [No Abstract]   [Full Text] [Related]  

  • 33. Promoting the Discussion of the Beneficial Effects of Ketamine to Treat Refractory Depression.
    Ghosh P; Viswanath O
    Psychopharmacol Bull; 2019 Feb; 49(1):98-99. PubMed ID: 30858644
    [No Abstract]   [Full Text] [Related]  

  • 34. No evidence for the effectiveness of IV ketamine for treatment resistant mood disorders in retrospective study.
    Munkholm K; Jørgensen KJ
    Bipolar Disord; 2020 Dec; 22(8):860-861. PubMed ID: 32981094
    [No Abstract]   [Full Text] [Related]  

  • 35. Concomitant benzodiazepine use attenuates ketamine response: implications for large scale study design and clinical development.
    Frye MA; Blier P; Tye SJ
    J Clin Psychopharmacol; 2015 Jun; 35(3):334-6. PubMed ID: 25928701
    [No Abstract]   [Full Text] [Related]  

  • 36. Real-world effectiveness of repeated ketamine infusions for treatment-resistant bipolar depression.
    Fancy F; Rodrigues NB; Di Vincenzo JD; Chau EH; Sethi R; Husain MI; Gill H; Tabassum A; Mckenzie A; Phan L; McIntyre RS; Rosenblat JD
    Bipolar Disord; 2023 Mar; 25(2):99-109. PubMed ID: 36516343
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ketamine as treatment for depression.
    Taiminen T
    Duodecim; 2017; 133(1):52-60. PubMed ID: 29199810
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation.
    McIntyre RS; Rosenblat JD; Nemeroff CB; Sanacora G; Murrough JW; Berk M; Brietzke E; Dodd S; Gorwood P; Ho R; Iosifescu DV; Lopez Jaramillo C; Kasper S; Kratiuk K; Lee JG; Lee Y; Lui LMW; Mansur RB; Papakostas GI; Subramaniapillai M; Thase M; Vieta E; Young AH; Zarate CA; Stahl S
    Am J Psychiatry; 2021 May; 178(5):383-399. PubMed ID: 33726522
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of the Trajectory of Depression Severity With Ketamine and Esketamine Treatment in a Clinical Setting.
    Nikayin S; Rhee TG; Cunningham ME; de Fontnouvelle CA; Ostroff RB; Sanacora G; Wilkinson ST
    JAMA Psychiatry; 2022 Jul; 79(7):736-738. PubMed ID: 35544190
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The immunomodulatory effect of ketamine in depression.
    Szałach ŁP; Lisowska KA; Słupski J; Włodarczyk A; Górska N; Szarmach J; Jakuszkowiak-Wojten K; Gałuszko-Węgielnik M; Wiglusz MS; Wilkowska A; Cubała WJ
    Psychiatr Danub; 2019 Sep; 31(Suppl 3):252-257. PubMed ID: 31488736
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.